Molecular CellMolecular BiologyPeer-reviewed journal article
Dominant-negative TP53 mutations potentiated by the HSF1-regulatedproteostasis network
Stephanie Halim, Rebecca M. SebastianiD, Kristi E. Liivak, Jessica E. PatrickiD, Tiffani HuiiD, David R. AmiciiD, Andrew O. GiacomelliiD, Paulina Rios, Vincent L. ButtyiD, William C. HahniD, Francisco J. Sánchez RiveraiD, Marc L. MendilloiD, Yu‐Shan LiniD, Matthew D. ShouldersiD
Abstract
Protein mutational landscapes are shaped by how amino acid substitutions affect stability and folding or aggregation kinetics. These properties are modulated by cellular proteostasis networks. Heat shock factor 1 (HSF1) is the master regulator of cytosolic and nuclear proteostasis. Chronic HSF1 ac-tivity upregulation is a hallmark of cancer cells, potentially because upregulated proteostasis factors fa-cilitate the acquisition and maintenance of oncogenic mutations. Here, we assess how HSF1 activation influences mutational trajectories by which p53 can escape cytotoxic pressure from nutlin-3, an inhibitor of the p53 regulator MDM2. HSF1 activation broadly increases the fitness of dominant-negative p53 substitutions, particularly non-conservative, biophysically unfavorable amino acid changes within buried regions of the p53 DNA-binding domain. These findings demonstrate that HSF1 activation reshapes the oncogenic mutational landscape by preferentially supporting the emergence and persistence of bio-physically disruptive, cancer-associated p53 substitutions, linking proteostasis network activity directly to oncogenic evolution.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 3th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Suppression of HSF1 activity by wildtype p53 creates the driving force for p53 loss-of-heterozygosity, enabling mutant p53 stabilization and invasion
O. C. Sener, A. Stender, … R. Schulz-Heddergott·bioRxiv·Apr 23, 2020
- Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression
Babul Moni Ram, Omprakash Shriwas, … Chengkai Dai·bioRxiv·May 24, 2024
- Oncogenic c-Myc activity increases tolerance to proteotoxic and genotoxic stress through regulation of HSF1
J. Jones, K. Kiso, … R. A. M. de Bruin·bioRxiv·Feb 2, 2022
- Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
Y. Lu, T. Cho, … D. Schramek·bioRxiv·Mar 13, 2022
- Distinct Proteasomal Pathways Drive Oncogenic PPM1D Activation
Ni Yan, Deumaya Shrestha, … Peter Grant Miller·bioRxiv·Jun 9, 2026
- Variable Mutations at the p53-R273 Oncogeic Hotspot Position Leads to Altered Properties
A. Garg, J. P. Hazra, … S. Sinha·bioRxiv·Jun 26, 2019